Cala Health, Inc., a San Francisco, CA-based bioelectronic medicine company developing wearable therapies for chronic disease has raised $50 million in Series C funding. New investors in the Series C funding round include Novartis, Baird Capital, LifeSci Venture Partners, TriVentures, and others. All existing investors participated in the round, including Johnson & Johnson Innovation – JJDC, Inc. (JJDC), Lux Capital, Lightstone Ventures, Action Potential Venture Capital, dRx Capital, and
Read More
Northwell Health, GE Ventures Form $200M Alliance to Develop, Commercialize Solutions in Bioelectronic Medicine
Today, GE Ventures announced a strategic partnership with Northwell Health’s Feinstein Institute for Medical Research providing up to $200 million in joint funding over seven years to support the opening of a new Center for Bioelectronic Medicine (CBEM), and advance diagnostic and therapeutic solutions for Alzheimer’s, cancer, diabetes, hypertension and more. The new alliance will greatly build upon groundbreaking work that started between the Feinstein Institute and a team of GE scientists
Read More